Published in Metabolism on November 01, 2004
Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med (2010) 1.50
Association of body fat with C-reactive protein in rheumatoid arthritis. Arthritis Rheum (2008) 1.06
Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. Eur J Appl Physiol (2010) 1.02
Adiponectin: Probe of the molecular paradigm associating diabetes and obesity. World J Diabetes (2015) 1.01
Maternal serum adiponectin multimers in gestational diabetes. J Perinat Med (2009) 0.94
Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight. J Perinat Med (2009) 0.92
Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes. Diabetes Care (2014) 0.91
Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus. Diabetol Metab Syndr (2014) 0.90
Low serum adiponectin concentrations are associated with insulin sensitivity independent of obesity in Sudanese subjects with type 2 diabetes mellitus. Diabetol Metab Syndr (2013) 0.85
Diabetes medications: Impact on inflammation and wound healing. J Diabetes Complications (2015) 0.81
Comparison of plasma adiponectin & certain inflammatory markers in angiographically proven coronary artery disease patients with & without diabetes--a study from India. Indian J Med Res (2014) 0.78
Activation of the LH receptor up regulates the type 2 adiponectin receptor in human granulosa cells. J Assist Reprod Genet (2013) 0.78
Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study. Open Cardiovasc Med J (2011) 0.77
Increased adipose tissue expression of TLR8 in obese individuals with or without type-2 diabetes: significance in metabolic inflammation. J Inflamm (Lond) (2016) 0.75
Obesity Paradox - The Controversial Role of Body Mass Index and Plasma Adiponectin in Coronary Artery Disease and Acute Coronary Syndrome. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2013) 0.75
Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice. Proc Natl Acad Sci U S A (2007) 3.40
Obesity-associated hypertension: new insights into mechanisms. Hypertension (2004) 2.86
CaMKII determines mitochondrial stress responses in heart. Nature (2012) 2.63
Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes (2005) 2.24
Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J Neurosci (2003) 2.14
Neuroendocrine tumors. J Natl Compr Canc Netw (2012) 1.91
Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Invest (2004) 1.74
Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation (2003) 1.69
Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin. Diabetes (2008) 1.60
Differential modulation of leptin-induced sympathoexcitation by baroreflex activation. J Hypertens (2002) 1.57
What is the most appropriate methodology for detection of conduit artery endothelial dysfunction? Arterioscler Thromb Vasc Biol (2007) 1.56
Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity. J Neurosci (2009) 1.54
Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw (2015) 1.51
Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression. J Biol Chem (2004) 1.46
Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens (2002) 1.45
Effect of hyperhomocysteinemia on protein C activation and activity. Blood (2002) 1.45
Impairments in microvascular reactivity are related to organ failure in human sepsis. Am J Physiol Heart Circ Physiol (2007) 1.42
Impaired skeletal muscle and skin microcirculatory function in human obesity. J Hypertens (2002) 1.42
The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes (2002) 1.37
Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria. J Biol Chem (2006) 1.35
Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension (2002) 1.31
Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry (2008) 1.26
Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity. Am J Physiol Endocrinol Metab (2004) 1.23
Leptin and the cardiovascular system. Recent Prog Horm Res (2004) 1.20
Vasculopathy related to manic/hypomanic symptom burden and first-generation antipsychotics in a sub-sample from the collaborative depression study. Psychother Psychosom (2012) 1.14
Superoxide and respiratory coupling in mitochondria of insulin-deficient diabetic rats. Endocrinology (2008) 1.11
Role of endothelin in cardiovascular disease. J Renin Angiotensin Aldosterone Syst (2002) 1.09
Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers. Curr Psychiatry Rev (2012) 1.08
Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension (2002) 1.07
Effects of aging and atherosclerosis on endothelial and vascular smooth muscle function in humans. Int J Cardiol (2005) 1.06
Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens Res (2011) 1.06
Neuropsychological performance is associated with vascular function in patients with atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol (2006) 1.05
Blood vessel function and cognition in elderly patients with atherosclerosis. Stroke (2004) 1.05
Mitochondrial function in diabetes: novel methodology and new insight. Diabetes (2013) 1.02
Antecedent hypoglycemia, catecholamine depletion, and subsequent sympathetic neural responses. Endocrinology (2006) 0.98
Evidence for accelerated vascular aging in bipolar disorder. J Psychosom Res (2012) 0.98
Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes. J Diabetes Complications (2007) 0.97
Mitochondrial proton leak in obesity-resistant and obesity-prone mice. Am J Physiol Regul Integr Comp Physiol (2007) 0.97
Leptin potentiates thermogenic sympathetic responses to hypothermia: a receptor-mediated effect. Diabetes (2002) 0.96
Respiratory uncoupling by UCP1 and UCP2 and superoxide generation in endothelial cell mitochondria. Am J Physiol Endocrinol Metab (2004) 0.96
Periodontal disease and atherosclerosis: from dental to arterial plaque. Arterioscler Thromb Vasc Biol (2003) 0.95
UCP2-dependent proton leak in isolated mammalian mitochondria. J Biol Chem (2001) 0.95
Homocysteine: is it a clinically important cardiovascular risk factor? Cleve Clin J Med (2004) 0.94
Homocysteine: role and implications in atherosclerosis. Curr Atheroscler Rep (2006) 0.93
Cyclic changes in glycemia assessed by continuous glucose monitoring system during multiple complete menstrual cycles in women with type 1 diabetes. Diabetes Technol Ther (2004) 0.93
Superoxide production by mitochondria of insulin-sensitive tissues: mechanistic differences and effect of early diabetes. Metabolism (2009) 0.91
Vascular smooth muscle function is associated with initiation and processing speed in patients with atherosclerotic vascular disease. J Int Neuropsychol Soc (2008) 0.91
Loss of leptin actions in obesity: two concepts with cardiovascular implications. Clin Exp Hypertens (2005) 0.90
Dietary fat, fatty acid saturation and mitochondrial bioenergetics. J Bioenerg Biomembr (2014) 0.89
Bioenergetic effects of mitochondrial-targeted coenzyme Q analogs in endothelial cells. J Pharmacol Exp Ther (2012) 0.89
Endothelial cell and platelet bioenergetics: effect of glucose and nutrient composition. PLoS One (2012) 0.89
Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease. Nephrol Dial Transplant (2007) 0.89
Rate of weight gain and cardiometabolic abnormalities in children and adolescents. J Pediatr (2012) 0.88
Endothelial effects of leptin: implications in health and diseases. Curr Diab Rep (2005) 0.88
Mitochondrial superoxide and coenzyme Q in insulin-deficient rats: increased electron leak. Am J Physiol Regul Integr Comp Physiol (2011) 0.87
Cardiovascular and sympathetic effects of leptin. Curr Hypertens Rep (2002) 0.87
Arterial compliance and endothelial function. Curr Diab Rep (2007) 0.86
Peroxisome proliferator-activated receptor γ decouples fatty acid uptake from lipid inhibition of insulin signaling in skeletal muscle. Mol Endocrinol (2012) 0.86
Mitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cells. PLoS One (2009) 0.85
Role of xanthine oxidase in conduit artery endothelial dysfunction in cigarette smokers. Am J Cardiol (2004) 0.84
Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders. Pharmacotherapy (2011) 0.84
Triglyceride-rich lipoproteins and vascular function. Arterioscler Thromb Vasc Biol (2003) 0.84
Obesity-related hypertension: is there a role for selective leptin resistance? Curr Hypertens Rep (2004) 0.84
Endogenous peroxisome proliferator-activated receptor-gamma augments fatty acid uptake in oxidative muscle. Endocrinology (2008) 0.83
Vascular function is not impaired early in the course of bipolar disorder. J Psychosom Res (2012) 0.83
Sodium nitrite in patients with peripheral artery disease and diabetes mellitus: safety, walking distance and endothelial function. Vasc Med (2013) 0.83
Leptin and body fat in type 2 diabetes and monodrug therapy. J Clin Endocrinol Metab (2003) 0.82
Body fat indices and biomarkers of inflammation: a cross-sectional study with implications for obesity and peri-implant oral health. Int J Oral Maxillofac Implants (2014) 0.82
Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents. Psychiatr Genet (2009) 0.82
White matter fractional anisotropy is inversely related to anxious symptoms in older adults with atherosclerosis. Int J Geriatr Psychiatry (2013) 0.81
Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study. Clin Nephrol (2012) 0.81
Acute neuropsychological functioning following cardiosurgical interventions associated with the production of intraoperative cerebral microemboli. Clin Neuropsychol (2002) 0.81
Screening, diagnosis, and treatment of dyslipidemia among persons with persistent mental illness: a literature review. Psychiatr Serv (2012) 0.80
Lack of dilator effect of leptin in the hindlimb vascular bed of conscious rats. Eur J Pharmacol (2005) 0.80
A role for plasminogen activator inhibitor-1 in obesity: from pie to PAI? Arterioscler Thromb Vasc Biol (2006) 0.80
Predictors of subjective cognitive difficulties in older adults with atherosclerotic vascular disease. Am J Geriatr Psychiatry (2007) 0.80
Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension. Clin Sci (Lond) (2002) 0.80
Alpha 2-Adrenergic stimulation is protective against ischemia-reperfusion-induced ventricular arrhythmias in vivo. Am J Physiol Heart Circ Physiol (2002) 0.79
Effect of an insulin-like growth factor binding protein fusion protein on thymidine incorporation in neuroblastoma and rhabdomyosarcoma cell lines. Endocrinology (2004) 0.79
Sildenafil increases sympathetically mediated vascular tone in humans. Am J Hypertens (2013) 0.79
Uncoupling metabolism and coupling leptin to cardiovascular disease. Arterioscler Thromb Vasc Biol (2002) 0.79
Hemodynamic consequences of neuropeptide Y-induced obesity. Am J Hypertens (2002) 0.79
Gene expression of vitamin D metabolic enzymes at baseline and in response to vitamin D treatment in thyroid cancer cell lines. Oncology (2012) 0.78
Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome. Fertil Steril (2006) 0.78
Sibutramine and the sympathetic nervous system in obese humans. Clin Auton Res (2005) 0.78
Antecedent caloric intake and glucose excursion following a subsequent meal in Type 1 diabetes. J Diabetes (2009) 0.78
Finger volume pulse waveforms facilitate reliable assessment of heart rate variability, but not blood pressure variability or baroreflex function. BMC Cardiovasc Disord (2014) 0.78
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine. Obesity (Silver Spring) (2007) 0.78
T3 augmentation in major depressive disorder: safety considerations. Am J Psychiatry (2011) 0.77
Effects of antipsychotic drugs on cardiovascular variability in participants with bipolar disorder. Hum Psychopharmacol (2014) 0.77
Association of anxiety with resistance vessel dysfunction in human atherosclerosis. Psychosom Med (2013) 0.77
Leptin administration to normal rats does not alter catecholamine responsiveness to insulin-induced hypoglycemia. Metabolism (2003) 0.77
Gender differences in neuropsychological performance in individuals with atherosclerosis: impact of vascular function. J Clin Exp Neuropsychol (2010) 0.77